Immunotherapy, Biologics and Immune Modulation
This session covers therapeutic approaches that activate, suppress, or modify immune responses for the treatment of immune-mediated diseases and related conditions. It includes biologics, monoclonal antibodies, cytokine-targeted therapies, cellular therapies, small-molecule agents, immune tolerance strategies, and combination treatments.
Abstract Scope and Participation
Abstracts may present clinical trials, real-world evidence, treatment response, adverse effects, therapeutic monitoring, mechanisms of action, drug development, and personalized treatment selection. The session welcomes clinicians, immunologists, pharmacologists, researchers, biotechnology professionals, regulatory experts, and healthcare teams involved in immune-based therapeutics.
Committee Members
Paulo Cesar De Morais
Catholic University of Brasília, Brazil
Francis J Castellino
University of Notre Dame, United States
Sergey Victorovich Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation ICIAA 2027 Speakers
Sergey Victorovich Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Francis J Castellino
University of Notre Dame, United States
Paulo Cesar De Morais
Catholic University of Brasília, BrazilSubmit your abstract Today
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Targeting tumor-associated antigens through variable epitope libraries: Antitumor activity in breast cancer and acute myeloid leukemia
Braulio Alejandro Martinez Zarco, UNAM, Mexico
Title : Ultra-low-dose methotrexate combined with low-dose prednisolone in two distinct chronic disorders: A hypothesis-generating clinical comparison
Naylya Djumaeva, Research Institute of Virology, Uzbekistan
Title : Treatment outcomes of adult Filipino patients with drug susceptible pulmonary and extrapulmonary tuberculosis after anti-Koch’s rechallenge regimen
Jizelle Kay Cofulan Fang Asan, Baguio General Hospital and Medical Center, Philippines
Title : Clinical, immunological, and cytokine profiles of primary Sjögren’s syndrome in a Western Algerian population
Ouikhlef Narjesse, EHU Oran & Faculty of Medicine of Oran, Algeria